|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 401 9th St. NW |
Address2 | Suite 720 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 72111-1004241
|
||||||||
|
6. House ID# 359400036
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Tracy Spicer |
Date | 10/20/2020 5:06:04 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Stark Law modernization;
S. 966, Medicare Care Coordination Improvement Act of 2019;
H.R. 2282, Medicare Care Coordination Improvement Act of 2019;
Monitor implementation of Section 603 of the Bipartisan Budget Act of 2015 and site neutral policies;
Issues related to Advance Notice of Proposed Rulemaking (ANPR) on International Pricing Index (IPI) and Part B reforms;
S. 1895, Lower Health Care Costs Act;
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;
S. 1531; Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 668/H.R. 1570, Removing Barriers to Colorectal Cancer Screening Act of 2019;
S. 2543, Prescription Drug Pricing Reduction Act of 2019;
H.R. 925, The Heroes Act;
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, Public Law 116-159;
S 4230, Telehealth Expansion Act of 2020;
S.3750/HR 6837, Medicare Accelerated and Advance Payments Improvement Act of 2020;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Spicer |
|
|
|
Elizabeth |
Barnett |
|
|
|
Jordan |
LaCrosse |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 3559/H.R. 6365, A bill to provide emergency financial assistance to rural health care facilities and providers impacted by the COVID-19 emergency
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R. 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
H.R. 925, The Heroes Act;
Telehealth issues related to COVID-19;
Health disparities
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Spicer |
|
|
|
Elizabeth |
Barnett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |